This website uses cookies to enhance the user experience.
N

NEXTERA AS994 486 594

Research
Limited company
Gaustadalléen 21 0349 OSLO, Norge

NEXTERA AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
16 years
since Sep 14, 2009
Type
Limited company
VAT registered
Yes
Number of employees
9

Ownership

Number of shares and share classes
4,095,627
1 share class
Total number of shareholders
59
27 companies, 32 persons

Financials

Total operating income 2023
12,650,318
NOK
Annual total result 2023
-39,470,359
NOK
Total equity 2023
14,802,788
NOK
Last update: May 14, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
2.01 %
directly

Board

NameRoleShares
Chairman
15.07 %
indirectly
Board Member-
Board Member
5.25 %
directly
Board Member-
Board Member-
Board Member-

Others

NameRoleShares
P
PRICEWATERHOUSECOOPERS AS
Auditor-
A
AMESTO ACCOUNTHOUSE AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Chairman
15.07 %
indirectly
-
9.34 %
indirectly
-
6.44 %
indirectly
-
5.58 %
indirectly
Board Member
5.25 %
directly
-
2.26 %
indirectly
Managing Director/CEO
2.01 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
NO0010848534
791,184
19.32 %
B
BIRK VENTURE AS
NO0010848534
617,415
15.07 %
S
SUNDT AS
NO0010848534
456,260
11.14 %
NO0010848534
337,644
8.24 %
NO0010848534
298,225
7.28 %
NO0010848534
298,225
7.28 %
R
RO INVEST AS
NO0010848534
228,718
5.58 %
NO0010848534
215,180
5.25 %
H
HELENE SUNDT AS
NO0010848534
154,222
3.77 %
I
INVEN2 AS
NO0010848534
116,471
2.84 %
NO0010848534
82,420
2.01 %
M
MYRLID AS
NO0010848534
61,586
1.5 %
J
JANDERSEN KAPITAL AS
NO0010848534
61,586
1.5 %
A
AS BEMACS
NO0010848534
42,860
1.05 %
NO0010848534
40,000
0.98 %
C
CGS HOLDING AS
NO0010848534
35,700
0.87 %
S
SES AS
NO0010848534
27,913
0.68 %
NO0010848534
27,400
0.67 %
B
BASEN KAPITAL AS
NO0010848534
22,597
0.55 %
O
OSLOTECH AS
NO0010848534
22,440
0.55 %
NO0010848534
15,826
0.39 %
C
Cat Invest 1 AS
NO0010848534
14,814
0.36 %
NO0010848534
14,671
0.36 %
G
GILLESEN OVERSEAS & CO AS
NO0010848534
11,760
0.29 %
K
KISTEFOS AS
NO0010848534
11,500
0.28 %
B
BRØDRENE LONDON AS
NO0010848534
10,830
0.26 %
V
VIOLINA AS
NO0010848534
8,917
0.22 %
NO0010848534
8,803
0.21 %
NO0010848534
7,359
0.18 %
C
CAPRECA AS
NO0010848534
7,140
0.17 %
NO0010848534
6,493
0.16 %
G
GEZINA AS
NO0010848534
5,620
0.14 %
R
ROLFS HOLDING AS
NO0010848534
4,000
0.1 %
NO0010848534
3,540
0.09 %
S
SANDLIE AS
NO0010848534
3,250
0.08 %
H
HOLSTEIN AS
NO0010848534
2,860
0.07 %
NO0010848534
2,280
0.06 %
NO0010848534
2,140
0.05 %
NO0010848534
2,000
0.05 %
NO0010848534
1,511
0.04 %
NO0010848534
1,244
0.03 %
NO0010848534
1,190
0.03 %
NO0010848534
1,190
0.03 %
C
CELIO AS
NO0010848534
1,189
0.03 %
NO0010848534
1,000
0.02 %
NO0010848534
920
0.02 %
D
DIONE AS
NO0010848534
900
0.02 %
NO0010848534
811
0.02 %
NO0010848534
735
0.02 %
NO0010848534
648
0.02 %
NO0010848534
541
< 0.01 %
NO0010848534
520
< 0.01 %
NO0010848534
432
< 0.01 %
NO0010848534
380
< 0.01 %
NO0010848534
162
< 0.01 %
NO0010848534
140
< 0.01 %
D
DAVE INVEST AS
NO0010848534
100
< 0.01 %
A
ARCTIC SECURITIES AS
NO0010848534
100
< 0.01 %
NO0010848534
65
< 0.01 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year202320222021
Total operating income
12,650,318
14,539,400
9,130,639
Annual Total Result
-39,470,359
-18,664,603
-14,560,023
Total assets
22,430,790
60,276,603
32,824,661
Total liabilities
7,628,002
6,003,455
4,660,229
Total equity
14,802,788
54,273,147
28,164,431

P&L

Year202320222021
Total operating income
12,650,318
14,539,400
9,130,639
Total operating costs
53,175,588
33,415,133
23,710,902
Operating result
-40,525,270
-18,875,733
-14,580,263
Financial income/costs
1,054,911
211,130
20,240
Profit before tax
-39,470,359
-18,664,603
-14,560,023
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-39,470,359
-18,664,603
-14,560,023

Balance overview

Year202320222021
Total fixed assets
4,735,052
3,745,378
2,177,476
Total current assets
17,695,737
56,531,225
30,647,185
Total assets
22,430,790
60,276,603
32,824,661
Short term debt
7,628,002
6,003,455
4,660,229
Long term debt
0
0
0
Total liabilities
7,628,002
6,003,455
4,660,229
Contributed capital
14,802,788
54,273,147
28,164,431
Retained earnings
0
0
0
Total equity
14,802,788
54,273,147
28,164,431
Total equity and liabilities
22,430,790
60,276,602
32,824,660

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology